2014
DOI: 10.4330/wjc.v6.i10.1091
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseases

Abstract: Mitochondria are one of the major sites for the generation of reactive oxygen species (ROS) as an undesirable side product of oxidative energy metabolism. Damaged mitochondria can augment the generation of ROS. Dysfunction of mitochondria increase the risk for a large number of human diseases, including cardiovascular diseases (CVDs). Heart failure (HF) following ischemic heart disease, infantile cardiomyopathy and cardiac hypertrophy associated with left ventricular dilations are some of the CVDs in which the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
41
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(43 citation statements)
references
References 65 publications
1
41
0
1
Order By: Relevance
“…In Germany injected ALA is a prescription medicine to treat type II diabetes [16] [17]. On the other hand, clinical trials with ALA have failed to produce data that are consistent with the results reported by Xiong et al, although specific endpoints consistent with this report have not explored [18] [19] [20] [21].…”
Section: Medical Implicationssupporting
confidence: 74%
“…In Germany injected ALA is a prescription medicine to treat type II diabetes [16] [17]. On the other hand, clinical trials with ALA have failed to produce data that are consistent with the results reported by Xiong et al, although specific endpoints consistent with this report have not explored [18] [19] [20] [21].…”
Section: Medical Implicationssupporting
confidence: 74%
“…Both compounds have been extensively used as tools to probe the role of ROS in physiological and pathophysiological processes (Zafarullah et al . ; Ajith & Jayakumar, ). Our previous studies demonstrated that N ‐acetylcysteine at 1 m m effectively ablated hypoxia‐ and noradrenaline‐stimulated ROS generation in H9c2 cells and intact fetal hearts (Patterson et al .…”
Section: Methodsmentioning
confidence: 99%
“…Earlier studies conducted by Ajith et al (2014) in our laboratory demonstrated the TCA cycle stimulating activity of G.lucidum 2010). DOX form complexes with metals like Fe 3+ and Cu 2+ .…”
Section: Discussion:-mentioning
confidence: 81%